Skip to content
Home/Companies/Biotech/Arzeda
Arzeda

Arzeda

Biotech·United States·Active·4yr hold
Entry
2022
Hold
4yr
Status
Active

Who owns Arzeda?

Arzeda is an American Biotech company, currently owned by Sofinnova Partners since 2022.

Hand-verified · updated 2026-09-30

Open JSON · CC-BY
Sofinnova Partners
Investor
Sofinnova Partners
Sofinnova Industrial Biotech · 2018 · VC

Key facts

HQUnited States
SectorBiotech
Websitewww.arzeda.com

More from Sofinnova Industrial Biotech

Other portfolio companies in the same fund.

P2 Science
P2 Science
Active
IndustrialsUnited States· 2026
IB Works I
Exited 2024
SoftwareFrance· 2022
Prometheus Materials
Prometheus Materials
Active
BiotechUS· 2022
Novameat
Novameat
Active
BiotechSpain· 2021
Qorium
Qorium
Active
BiotechNetherlands· 2021
Verley (formerly Bon Vivant)
Verley (formerly Bon Vivant)
Active
BiotechFrance· 2021

More PE-backed in Biotech

Comparable biotech deals from other GPs.

Abbisko Healthcare
Active
The Carlyle GroupChina
Adagene
Active
General AtlanticChina
Advanced Cell Diagnostics
Active
Summit PartnersUS
Akero Therapeutics
Akero Therapeutics
Active
General AtlanticUS
Aldevron
Aldevron
Active
TA AssociatesUS
Alloy Therapeutics
Alloy Therapeutics
Active
Mubadala CapitalUS

Questions

Who owns Arzeda?

Arzeda is currently owned by Sofinnova Partners, through Sofinnova Industrial Biotech, since 2022.

When did Sofinnova Partners acquire Arzeda?

Sofinnova Partners acquired Arzeda in 2022.

Look up another firm or company
Data refreshed weekly · Sourced from public filings · Report an issue